Jong Seok Lee

发表

Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination

Yu-Na Lee, Young‐Tae Lee, Min-chul Kim, 2014, Immunology.

Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.

Yu-Na Lee, Min-chul Kim, Ki-hye Kim, 2014, Antiviral research.

Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity.

Yu-Jin Jung, Yu-Na Lee, Yu-Jin Kim, 2014, Vaccine.

Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells

Yu-Jin Jung, Yu-Na Lee, Young‐Tae Lee, 2015, PloS one.

Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.

R. Compans, F. Quan, Yu-Na Lee, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Ginseng Protects Against Respiratory Syncytial Virus by Modulating Multiple Immune Cells and Inhibiting Viral Replication

Yu-Na Lee, Young‐Tae Lee, Min-chul Kim, 2015, Nutrients.

Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2015, International journal of nanomedicine.

Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.

Yu-Jin Jung, Yu-Na Lee, Young‐Tae Lee, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Antiviral activity of ginseng extract against respiratory syncytial virus infection

Yu-Na Lee, Min-chul Kim, Sang-Moo Kang, 2014, International journal of molecular medicine.

Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells

Young‐Tae Lee, Min-chul Kim, Ki-hye Kim, 2015, Journal of Virology.

AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection.

Yu-Na Lee, Young‐Tae Lee, Min-chul Kim, 2014, Vaccine.

Immunomodulatory Activity of Red Ginseng against Influenza A Virus Infection

Yu-Na Lee, Min-chul Kim, Sang-Moo Kang, 2014, Nutrients.

p90 RSK2 Mediates Antianoikis Signals by both Transcription-Dependent and -Independent Mechanisms

J. Taunton, F. Khuri, Z. Chen, 2013, Molecular and Cellular Biology.

Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.

F. Quan, Young‐Tae Lee, Min-chul Kim, 2014, Vaccine.

Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Jian-Dong Li, Yu-Jin Jung, Young‐Tae Lee, 2014, Antiviral research.

Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.

Carlo Montemagno, Min-Chul Kim, Hyo-Jick Choi, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.

F. Quan, Young‐Tae Lee, Min-chul Kim, 2015, Nanomedicine : nanotechnology, biology, and medicine.

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.

Yu-Jin Jung, Yu-Jin Kim, Young‐Tae Lee, 2016, Virology.

Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Human vaccines & immunotherapeutics.

Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.

Young‐Tae Lee, Min-chul Kim, Sang-Moo Kang, 2015, Antiviral research.

p90 RSK2 Mediates Antianoikis Signals by both Transcription-Dependent and -Independent Mechanisms

J. Taunton, F. Khuri, Z. Chen, 2013, Molecular and Cellular Biology.